The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The protections extend through at least 2035, with the potential for further extensions
The NeuroSakhi initiative aims to close these gaps by strengthening awareness, building patient support networks and improving engagement between healthcare professionals, patients and caregivers across Punjab
The interim results of the Phase 3 SUCCESSOR-2 study's safety profile aligned with expectations for both mezigdomide and the combination regimen
The conditional, time-limited approval comes through a joint effort with RACTHERA, a joint venture in which Sumitomo Chemical holds a 66.6% stake and Sumitomo Pharma holds 33.4%
This new treatment option can redefine how we approach RRMM treatment by giving healthcare providers a regimen with improvement in PFS and OS and a well-characterized safety profile
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
The results, published in The Lancet, showed orforglipron delivered significantly greater reductions in both A1C and body weight across primary and key secondary endpoints
The new patents cover critical advancements in cochlear implant technology
Subscribe To Our Newsletter & Stay Updated
